UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Update on COVID-19 Myocarditis

Medicina (Kaunas, Lithuania), 2020-12, Vol.56 (12), p.678

2020

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation and heart failure: intersecting populations, morbidities, and mortality

Heart failure reviews, 2014-05, Vol.19 (3), p.285-293

2014

Link zum Volltext

Verfügbarkeit prüfen

Hypotension on cardiopulmonary stress test predicts 90 day mortality after LVAD implantation in INTERMACS 3–6 patients

ESC Heart Failure, 2022-10, Vol.9 (5), p.3496-3504

2022

Link zum Volltext

Verfügbarkeit prüfen

Furosemide Reimagined: Novel Subcutaneous Formulation for a 50-Year-Old Loop Diuretic Agent for the Treatment of Acute Decompensated Heart Failure

JACC. Heart failure, 2018-01, Vol.6 (1), p.71-72

2018

Link zum Volltext

Verfügbarkeit prüfen

Nitroprusside in Critically Ill Patients with Left Ventricular Dysfunction and Aortic Stenosis

The New England journal of medicine, 2003-05, Vol.348 (18), p.1756-1763

2003

Link zum Volltext

Verfügbarkeit prüfen

Histamine, Mast Cells, and Heart Failure: Is There a Connection?Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology

Journal of the American College of Cardiology, 2006-10, Vol.48 (7), p.1385

2006

Link zum Volltext

Verfügbarkeit prüfen

Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial

Archives of internal medicine (1960), 2007-10, Vol.167 (18), p.1998

2007

Link zum Volltext

Verfügbarkeit prüfen

Vasopressin receptor antagonists: will the "vaptans" fulfill their promise?

JAMA : the journal of the American Medical Association, 2004-04, Vol.291 (16), p.2017

2004

Link zum Volltext

Verfügbarkeit prüfen

TNF-alpha and heart failure. The difference between proof of principle and hypothesis testing

Circulation (New York, N.Y.), 1999-06, Vol.99 (25), p.3213-3214

Francis, G S

1999

Link zum Volltext

Verfügbarkeit prüfen

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial

JAMA : the journal of the American Medical Association, 2005-10, Vol.294 (13), p.1625

2005

Link zum Volltext

Verfügbarkeit prüfen

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

The New England journal of medicine, 1984-09, Vol.311 (13), p.819-823

1984

Link zum Volltext

Verfügbarkeit prüfen

Novel pharmacological treatments for heart failure

Expert opinion on investigational drugs, 2003-11, Vol.12 (11), p.1791-1801

2003

Link zum Volltext

Verfügbarkeit prüfen

PCSK9 inhibitors and their use in advanced heart failure and heart transplant recipients

Vessel Plus, 2020-12, Vol.2020

2020

Link zum Volltext

Verfügbarkeit prüfen

Diabetic cardiomyopathy: fact or fiction?

Heart (British Cardiac Society), 2001-03, Vol.85 (3), p.247-248

FRANCIS, GARY S

2001

Link zum Volltext

Verfügbarkeit prüfen

Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-11, Vol.326 (19), p.1919

2021

Link zum Volltext

Verfügbarkeit prüfen

Spironolactone inchronic heart failure:all's well that ends wellEditorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology

Journal of the American College of Cardiology, 2003-01, Vol.41 (2), p.215

2003

Link zum Volltext

Verfügbarkeit prüfen

Should we consider aldosterone as the primary screening target for preventing cardiovascular events?Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology

Journal of the American College of Cardiology, 2005-04, Vol.45 (8), p.1249

2005

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiology of congestive heart failure

Reviews in cardiovascular medicine, 2003, Vol.4 Suppl 2, p.S14-S20

2003

Link zum Volltext

Verfügbarkeit prüfen

Editorial: ACE inhibition in cardiovascular disease

The New England journal of medicine, 2000-01, Vol.342 (3), p.201

Francis, Gary S

2000

Link zum Volltext

Verfügbarkeit prüfen

Effects of sodium nitroprusside in aortic stenosis associated with severe heart failure: pressure-volume loop analysis using a numerical model

American journal of physiology. Heart and circulatory physiology, 2005, Vol.57 (1), p.H416-H423

2005

Link zum Volltext

Verfügbarkeit prüfen

Receptor systems involved in norepinephrine release in heart failure: Focus on dopaminergic systems

Clinical cardiology (Mahwah, N.J.), 1995-03, Vol.18 (S1), p.I-13-I-16

Francis, Gary S.

1995

Link zum Volltext

Verfügbarkeit prüfen

National academy of clinical biochemistry laboratory medicine practice guidelines : Clinical characteristics and utilization of biochemical markers in acute coronary syndromes

Clinical chemistry (Baltimore, Md.), 2007-04, Vol.53 (4), p.552-574

2007

Link zum Volltext

Verfügbarkeit prüfen

National academy of clinical biochemistry and IFCC committee for standardization of markers of cardiac damage laboratory medicine practice guidelines : Analytical issues for biochemical markers of acute coronary syndromes

Clinical chemistry (Baltimore, Md.), 2007-04, Vol.53 (4), p.547-551

APPLE, Fred S

2007

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure

The New England journal of medicine, 1991-08, Vol.325 (5), p.303-310

1991

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure

JACC. Heart failure, 2017-05, Vol.5 (5), p.317-326

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

ThemaHeart Failure

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Update on COVID-19 Myocarditis

Atrial fibrillation and heart failure: intersecting populations, morbidities, and mortality

Hypotension on cardiopulmonary stress test predicts 90 day mortality after LVAD implantation in INTERMACS 3–6 patients

Furosemide Reimagined: Novel Subcutaneous Formulation for a 50-Year-Old Loop Diuretic Agent for the Treatment of Acute Decompensated Heart Failure

Nitroprusside in Critically Ill Patients with Left Ventricular Dysfunction and Aortic Stenosis

Histamine, Mast Cells, and Heart Failure: Is There a Connection?Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology

Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial

Vasopressin receptor antagonists: will the "vaptans" fulfill their promise?

TNF-alpha and heart failure. The difference between proof of principle and hypothesis testing

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

Novel pharmacological treatments for heart failure

PCSK9 inhibitors and their use in advanced heart failure and heart transplant recipients

Diabetic cardiomyopathy: fact or fiction?

Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial

Spironolactone inchronic heart failure:all's well that ends wellEditorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology

Should we consider aldosterone as the primary screening target for preventing cardiovascular events?Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology

Pathophysiology of congestive heart failure

Editorial: ACE inhibition in cardiovascular disease

Effects of sodium nitroprusside in aortic stenosis associated with severe heart failure: pressure-volume loop analysis using a numerical model

Receptor systems involved in norepinephrine release in heart failure: Focus on dopaminergic systems

National academy of clinical biochemistry laboratory medicine practice guidelines : Clinical characteristics and utilization of biochemical markers in acute coronary syndromes

National academy of clinical biochemistry and IFCC committee for standardization of markers of cardiac damage laboratory medicine practice guidelines : Analytical issues for biochemical markers of acute coronary syndromes

A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure

Aktive Filter

Suchergebnisse filtern